Goodwin is adding a real estate partner to its roster in New York and David Phelps to its Los Angeles office. Read the announcement in The American Lawyer here.
Related Content
- Big Molecule WatchMay 15, 2024
Amgen and Sandoz Settle Denosumab BPCIA Litigation
- Big Molecule WatchMay 14, 2024
Alexion’s Preliminary Injunction Motion Denied in Eculizumab BPCIA Litigation Against Samsung Bioepis
- Big Molecule WatchMay 10, 2024
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders
- Life Sciences PerspectivesMay 10, 2024
2nd BCLT Advanced Life Sciences Institute
- Big Molecule WatchMay 9, 2024
IRA Litigation Updates: D.N.J. Rejects Challenges from BMS and Janssen; Four Cases Now on Appeal
- InsightMay 6, 2024
Which Jobs More Frequently Require Non-Compete Agreements?
- Big Molecule WatchMay 3, 2024
FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars
- Big Molecule WatchMay 2, 2024
Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf)
- Press ReleaseMay 17, 2024
Proteologix to be Acquired by Johnson & Johnson For $850 Million
- Press ReleaseMay 17, 2024
Flagship Pioneering and Novo Nordisk Partner on Research Collaboration with Metaphore Biotechnologies, Inc.
- Press ReleaseMay 17, 2024
ARTBIO and Fog Pharmaceuticals Collaborate on Research
- Press ReleaseMay 13, 2024
Goodwin advises Templewater on Multiple Healthcare Acquisitions
- Press ReleaseMay 9, 2024
Royalty Pharma To Acquire Royalty Interest In ImmuNext’s Frexalimab
- Press ReleaseMay 7, 2024
BridgeBio Oncology Therapeutics Completes $200 Million Private Financing
- Press ReleaseMay 6, 2024
Goodwin Bolsters Leading Life Sciences Practice with Partner Michael Siekman in Boston
- Press ReleaseMay 6, 2024
Delphia Therapeutics Completes $67 Million Series A